Related Experiment Video
Updated: Jul 6, 2026

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
Cerebral apoptosis in severe traumatic brain injury patients: an in vitro, in vivo, and postmortem study
Eduardo Miñambres1, Maria Angeles Ballesteros, Marta Mayorga
1Service of Intensive Care, Hospital Universitario Marqués de Valdecilla, Avenida Marqués de Valdecilla s/n, Santander, Spain.
Abstract:
One of the most important recent observations in traumatic brain injury (TBI) relates to the potential role of apoptosis in secondary brain injury. We aimed to analyze the presence of apoptosis and the expression of apoptosis-related proteins in brain samples from patients with TBI. We also tried to find any association between the in situ results and the in vitro observations in a neuronal model of induced-apoptosis. Brain tissue from the pericontusional zone (PCZ) of patients with traumatic contusions and from post-mortem samples was analyzed. Immunohistochemical analyses of apoptosis-related proteins and the terminal deoxynucleotide transferase-mediated nick end labeling (TUNEL) method to determine the presence of apoptotic cells were performed. Apoptotic rates on neuronal cells induced by jugular bulb vein sera was determined by flow cytometry. TUNEL-positive cells were detected in all PCZ of traumatic contusions and in most of PCZ in post-mortem specimens (none in control; p = 0.026). In vivo samples showed higher expression of antiapoptotic proteins Bcl-2 (p = 0.027) and Bcl-XL (p = 0.014) than post-mortem samples. In autopsies, the expression of Fas and Bim (p < 0.05) were higher in PCZ than in the zone distal from the contusion. In vitro studies showed that apoptotic rate was an independent factor associated with mortality at 6 months (p = 0.014). In the receiving operator curve (ROC) curve, a cut-off point of 66.5% showed a sensitivity of 89.5% and specificity of 66.7% in the prediction of patients' death. Cerebral apoptosis is a prominent form of cell death in the PCZ of human traumatic cerebral contusions, and high rates of in vitro apoptosis are associated with a poorer prognosis after TBI.
Insights
Apoptosis, or programmed cell death, is a key factor in traumatic brain injury (TBI) secondary damage. Higher apoptosis rates in neuronal cells correlate with increased mortality risk following TBI.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Traumatic brain injury (TBI) can lead to secondary brain damage, with apoptosis emerging as a significant cellular mechanism.
- Understanding the role of apoptosis and related protein expression in TBI is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the presence and extent of apoptosis in brain tissue from TBI patients.
- To analyze the expression of apoptosis-related proteins in the pericontusional zone (PCZ) of TBI samples.
- To correlate in vivo findings with in vitro neuronal apoptosis models and patient prognosis.
Main Methods:
- Analysis of brain tissue from the PCZ of TBI patients and post-mortem samples using immunohistochemistry and TUNEL staining.
- Assessment of apoptosis-related protein expression, including Bcl-2, Bcl-XL, Fas, and Bim.
- In vitro studies using a neuronal model to determine apoptotic rates and their association with mortality via flow cytometry and ROC curve analysis.
Main Results:
- TUNEL-positive cells, indicating apoptosis, were detected in the PCZ of TBI and post-mortem samples.
- Higher expression of anti-apoptotic proteins (Bcl-2, Bcl-XL) was observed in vivo compared to post-mortem samples.
- Increased expression of Fas and Bim was noted in the PCZ compared to distal zones; in vitro, apoptotic rates independently predicted 6-month mortality.
Conclusions:
- Cerebral apoptosis is a prevalent form of cell death in the PCZ following human traumatic brain contusions.
- High in vitro apoptosis rates are significantly associated with a poorer prognosis and increased mortality in TBI patients.
- Apoptosis markers may serve as potential prognostic indicators for TBI severity and patient outcomes.

